HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system.
At HOOKIPA we are united by a set of core values and common beliefs which give meaning to our work and guide our daily behaviour.
How we see the future:
In the future, we envision a world in which medicines reinforce the natural ability of the body to prevent and cure serious diseases.
What we do:
We work to reprogram the immune system to more effectively combat cancer and infectious diseases.
What drives us:
We want to eliminate the suffering of patients with specific and severe medical problems, and while doing so, we want to grow as individuals, professionally and personally.
How we work:
We go for it, and we never give up.
How we collaborate:
We thrive on our differences.
We fight for innovation.
We challenge ourselves to act authentically and transparently.